The contractor shall perform assay development and validation to identify and evaluate efficacy of anti-HIV therapeutics and topical microbicides. Note: the validation process includes the…
Ended Awarded Last action
- Contract number
- 75N93020F00003
- Awardee
-
Southern Research Institute UEI CDZJAJJHJMH5
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $214,117
Award facts
- Contract value 100% obligated
- $214,117.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Birmingham, AL 35205, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$86,033 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $300,150 |
About this award
This is a federal contract award to Southern Research Institute, a non-profit research organization in Birmingham, Alabama, by the National Institute of Allergy and Infectious Diseases (NIAID). The contract, valued at $214,117.04, is for the development and validation of assays to identify and evaluate the efficacy of anti-HIV therapeutics and topical microbicides. This work supports NIAID's in vitro testing resource for HIV therapeutics and topical microbicides program. The contract is a Cost Plus Fixed Fee arrangement and was not set aside for a specific business type. Southern Research has a subcontract with Universite DU Quebec A Montreal to perform vector transfection work as part of this contract.
Description
The contractor shall perform assay development and validation to identify and evaluate efficacy of anti-HIV therapeutics and topical microbicides. Note: the validation process includes the determination and optimization of the accuracy, precision, RE
Quick answers
Who was awarded contract 75N93020F00003?
75N93020F00003 was awarded to Southern Research Institute by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 1, 2020.
How much is contract 75N93020F00003 worth?
The government has obligated $214,117 on 75N93020F00003.
Is contract 75N93020F00003 an order under another contract?
Yes. 75N93020F00003 is a delivery order under HHSN272201400010I, an indefinite delivery contract.
Was contract 75N93020F00003 competed?
The extent of competition for 75N93020F00003 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award